Announce Date | 05/08/2025 |
EPS Normalized Actual | $2.65 (Beat by $0.32) |
EPS GAAP Actual | $2.65 (Beat by $0.32) |
Revenue Actual | $0.39095B |
Revenue Surprise | Beat by $390.95M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $3.5 |
EPS GAAP Estimate | $3.5 |
Revenue Estimate | $0.468833333B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 12.8 | 16.85 | 12.30983 | 13.12177 | 1 |
Dec 2025 | 13.5325 | 15.93 | 12.25 | 14.5 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.65 | -0.50667 | 0.39095B | -8.86% | -40.45M |
FQ4 2024 (Dec 2024) | 2.34 | -0.834 | 0.385323B | -8.36% | -68M |
FQ3 2024 (Sep 2024) | 2.29 | -0.84 | 0.401301B | -4.57% | -47.72M |
FQ2 2024 (Jun 2024) | 2.37 | -0.778 | 0.416303B | -5.86% | -33.7M |
FQ1 2024 (Mar 2024) | 2.69 | 2.69 | 0.425586B | 3.25% | 425.59M |
FQ4 2023 (Dec 2023) | 2.63 | 2.63 | 0.417542B | 7.41% | 417.54M |
FQ3 2023 (Sep 2023) | 2.93 | 2.93 | 0.419644B | 12.12% | 419.64M |
FQ2 2023 (Jun 2023) | 3.05 | 3.05 | 0.440694B | 10.09% | 440.69M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
3.5
Consensus Revenue Estimates
0.468833333B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 3.27 | -- | 3.27 | 3.27 | 1 |
FQ3 2026 (Sep 2026) | 3.39 | -- | 3.39 | 3.39 | 1 |
FQ2 2026 (Jun 2026) | 3.28 | -- | 3.28 | 3.28 | 1 |
FQ1 2026 (Mar 2026) | 2.85 | 7.02 | 2.85 | 2.85 | 1 |
FQ4 2025 (Oct 2025) | 3.38333 | 30.84 | 3.22028 | 3.59975 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.42B | -- | 0.42B | 0.42B | 2 |
FQ3 2026 (Sep 2026) | 0.43B | -- | 0.43B | 0.43B | 2 |
FQ2 2026 (Jun 2026) | 0.44B | -- | 0.44B | 0.44B | 2 |
FQ1 2026 (Mar 2026) | 0.4B | 3.09 | 0.4B | 0.4B | 2 |
FQ4 2025 (Oct 2025) | 0.46B | 16.53 | 0.44B | 0.48B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.15667 | 2.65 | -0.50667 | -19.12% |
FQ4 2024 (Dec 2024) | 3.174 | 2.34 | -0.834 | -35.64% |
FQ3 2024 (Sep 2024) | 3.13 | 2.29 | -0.84 | -36.68% |
FQ2 2024 (Jun 2024) | 3.148 | 2.37 | -0.778 | -32.83% |
FQ1 2024 (Mar 2024) | 2.69 | 2.69 | 100% | |
FQ4 2023 (Dec 2023) | 2.63 | 2.63 | 100% | |
FQ3 2023 (Sep 2023) | 2.93 | 2.93 | 100% | |
FQ2 2023 (Jun 2023) | 3.05 | 3.05 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.43B | $0.39B | $-40.45M | -10.35% |
FQ4 2024 (Dec 2024) | $0.45B | $0.39B | $-68M | -17.65% |
FQ3 2024 (Sep 2024) | $0.45B | $0.4B | $-47.72M | -11.89% |
FQ2 2024 (Jun 2024) | $0.45B | $0.42B | $-33.7M | -8.09% |
FQ1 2024 (Mar 2024) | $0B | $0.43B | $425.59M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.42B | $417.54M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.42B | $419.64M | 100% |
FQ2 2023 (Jun 2023) | $0B | $0.44B | $440.69M | 100% |